CELC Latest Headlines

Abivax is the top performing biotechnology stock YTD

at seekingalpha.com (Mon, 22-Dec 4:07 PM)

Top 10 healthcare stocks according to YTD performance, as the sector holds steady

at seekingalpha.com (Mon, 22-Dec 9:59 AM)

Celcuity’s Phase 3 PIK3CA Mutant Cohort Now Fully Enrolled as Interim Data Reveals Median PFS of 19.7 Months for Intermittent Dose Group

Market Chameleon (Mon, 20-Oct 10:31 AM)

Gedatolisib Regimens Achieve Unprecedented Progression-Free Survival Gains in HR+/HER2- Advanced Breast Cancer: Phase 3 VIKTORIA-1 Results Highlight New Practice-Changing Potential

Market Chameleon (Mon, 20-Oct 7:05 AM)

Celcuity's Phase 3 VIKTORIA-1 Trial to Feature at 2025 ESMO Congress: Spotlight on Gedatolisib's Efficacy in Breast Cancer

Market Chameleon (Mon, 22-Sep 9:37 AM)